… First-line therapy with gefitinib as compared with standard chemotherapy prolongs …
case of surgical resection of residual disease after dramatic response to gefitinib therapy in …

… first report of surgical resection of residual disease after gefitinib treatment in patients with …
), an initial surgery would not offer a survival advantage and complete resection would not be …

… cal resection of residual disease after treatment with gefitinib have been reported. Takamochi
et al.described 2 cases of surgical resection of residual disease after gefitinib treatment in …

… Clinical courses of the four patients who underwent surgical resection of a regrown (cases
1 and 2) or residual (cases 3 and 4) primary lesion following treatment with gefitinib for TKI-…

… In conclusion, gefitinib provided an important alternate approach for neoadjuvant or
preoperative treatment in patients with locally advanced NSCLC even without EGFR mutations. …

… Patients were treated with preoperative gefitinib (250 mg once daily for 42 days), followed
by surgical resection. The primary endpoint was objective response rate (ORR); secondary …

… Complete surgical resection is the best way to cure patients with early-stage (I–III) non–small
cell lung cancers (NSCLCs). Pathologic stage is the most important prognostic factor for …

… Surgical resection is the most effective treatment for early … Despite complete surgical
resection, 50–60% of patients with … we had expected before gefitinib treatment. Thus, controversy …

… who had recurrent disease after surgery were retrospectively reviewed. All patients underwent
pulmonary resection at the Department of Thoracic Surgery, Aichi Cancer Center Hospital…

… Herein, we report a case of stage IV lung adenocarcinoma treated with surgical resection
after good response to gefitinib, which showed difficulty to dissect the pulmonary vessels and …